Work

A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia

Year: 2019

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-18-3728

Authors: Irene M. Ghobrial, Ravi Vij, David Siegel, Ashraf Badros, Jonathan Kaufman, Noopur Raje, Andrzej Jakubowiak, Michael R. Savona, Mihaela Obreja, Jesus G. Berdeja

Institutions: Dana-Farber Cancer Institute, Washington University in St. Louis, Hackensack University Medical Center, University of Maryland, Baltimore, Emory University, Winship Cancer Institute, Harvard University, Massachusetts General Hospital, University of Chicago Medical Center, Vanderbilt University, Amgen (United States), Sarah Cannon

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Amgen

OpenAlex ID: W2947718449

FWCI: 4.521

Cites: 24

Cited by: 48

Related to: 10